Merit Medical Systems EPS - Earnings per Share 2012-2026 | MMSI
Merit Medical Systems eps - earnings per share from 2012 to 2026. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Merit Medical Systems Annual EPS | |
|---|---|
| 2025 | $2.13 |
| 2024 | $2.03 |
| 2023 | $1.62 |
| 2022 | $1.29 |
| 2021 | $0.84 |
| 2020 | $-0.18 |
| 2019 | $0.10 |
| 2018 | $0.78 |
| 2017 | $0.55 |
| 2016 | $0.45 |
| 2015 | $0.53 |
| 2014 | $0.53 |
| 2013 | $0.39 |
| 2012 | $0.46 |
| 2011 | $0.58 |
| Merit Medical Systems Quarterly EPS | |
|---|---|
| 2026-03-31 | $0.68 |
| 2025-12-31 | $0.64 |
| 2025-09-30 | $0.46 |
| 2025-06-30 | $0.54 |
| 2025-03-31 | $0.49 |
| 2024-12-31 | $0.46 |
| 2024-09-30 | $0.48 |
| 2024-06-30 | $0.61 |
| 2024-03-31 | $0.48 |
| 2023-12-31 | $0.47 |
| 2023-09-30 | $0.44 |
| 2023-06-30 | $0.35 |
| 2023-03-31 | $0.36 |
| 2022-12-31 | $0.57 |
| 2022-09-30 | $0.27 |
| 2022-06-30 | $0.27 |
| 2022-03-31 | $0.18 |
| 2021-12-31 | $0.35 |
| 2021-09-30 | $0.21 |
| 2021-06-30 | $0.09 |
| 2021-03-31 | $0.19 |
| 2020-12-31 | $0.27 |
| 2020-09-30 | $-0.05 |
| 2020-06-30 | $-0.34 |
| 2020-03-31 | $-0.06 |
| 2019-12-31 | $-0.07 |
| 2019-09-30 | $-0.06 |
| 2019-06-30 | $0.12 |
| 2019-03-31 | $0.11 |
| 2018-12-31 | $0.17 |
| 2018-09-30 | $0.30 |
| 2018-06-30 | $0.21 |
| 2018-03-31 | $0.10 |
| 2017-12-31 | $0.11 |
| 2017-09-30 | $-0.07 |
| 2017-06-30 | $0.19 |
| 2017-03-31 | $0.32 |
| 2016-12-31 | $0.17 |
| 2016-09-30 | $0.02 |
| 2016-06-30 | $0.16 |
| 2016-03-31 | $0.10 |
| 2015-12-31 | $0.13 |
| 2015-09-30 | $0.11 |
| 2015-06-30 | $0.17 |
| 2015-03-31 | $0.12 |
| 2014-12-31 | $0.19 |
| 2014-09-30 | $0.18 |
| 2014-06-30 | $0.09 |
| 2014-03-31 | $0.07 |
| 2013-12-31 | $0.15 |
| 2013-09-30 | $0.13 |
| 2013-06-30 | $0.09 |
| 2013-03-31 | $0.02 |
| 2012-12-31 | $0.01 |
| 2012-09-30 | $0.17 |
| 2012-06-30 | $0.14 |
| 2012-03-31 | $0.14 |
| 2011-12-31 | $0.11 |
| 2011-09-30 | $0.11 |
| 2011-06-30 | $0.18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $4.072B | $1.516B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |